OPCH shares jump 34% as CD&R, McKesson agree to $5.8B takeover (OPCH:NASDAQ)
Option Care Health (OPCH) shares rose 34% after CD&R and McKesson (MCK) agreed to acquire the company for $32.05 per share, valuing it at $5.8B including debt. The deal is expected to close in 2024, subject to regulatory approval and OPCH shareholder approval.
How this was made
The 30-second read
Why it matters
The acquisition premium drives a sharp share rally, while McKesson's involvement may influence its balance sheet.
Market read
The deal represents a significant M&A event in the U.S. healthcare sector, prompting immediate price action.
What to watch
Financing terms and potential antitrust review may affect deal timing and valuation.
Background
Option Care Health, a specialty pharmacy, is being taken private by a consortium led by CD&R and McKesson.
Ticker impact
Option Care Health announced a definitive agreement to be acquired for $32.05 per share, valuing it at $5.8 B and triggering a 34% jump in its stock.
upward pressure as the market prices in the acquisition premium
The announced acquisition premium and immediate 34% move indicate strong buying interest.
McKesson is a co‑buyer in the $5.8 B acquisition of Option Care Health, making it a direct party to the deal.
neutral to slight pressure as investors assess financing and integration costs
Acquisition adds exposure to specialty pharmacy but may be offset by financing considerations.
Market effects
Consolidation in the specialty pharmacy sector may lift peers.
U.S. healthcare M&A activity gains momentum.
Highlights continued appetite for large‑scale health‑care deals worldwide.
Counterpoint
Deal could face regulatory scrutiny or integration risk, tempering upside.
Key entities
- CompanyOption Care Health
Target of the $5.8 B acquisition.
- CompanyMcKesson
Co‑buyer in the acquisition.
- Private equity firmCD&R
Lead investor in the deal.
